DK0501678T3 - Behandling af okulær hypertension med en synergistisk kombination - Google Patents

Behandling af okulær hypertension med en synergistisk kombination

Info

Publication number
DK0501678T3
DK0501678T3 DK92301412.0T DK92301412T DK0501678T3 DK 0501678 T3 DK0501678 T3 DK 0501678T3 DK 92301412 T DK92301412 T DK 92301412T DK 0501678 T3 DK0501678 T3 DK 0501678T3
Authority
DK
Denmark
Prior art keywords
treatment
ocular hypertension
synergistic combination
pharmaceutically acceptable
ketoprostaglandin
Prior art date
Application number
DK92301412.0T
Other languages
Danish (da)
English (en)
Inventor
Ryuji Ueno
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Application granted granted Critical
Publication of DK0501678T3 publication Critical patent/DK0501678T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK92301412.0T 1991-03-01 1992-02-20 Behandling af okulær hypertension med en synergistisk kombination DK0501678T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6132891 1991-03-01

Publications (1)

Publication Number Publication Date
DK0501678T3 true DK0501678T3 (da) 1996-05-28

Family

ID=13167964

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92301412.0T DK0501678T3 (da) 1991-03-01 1992-02-20 Behandling af okulær hypertension med en synergistisk kombination

Country Status (11)

Country Link
US (1) US5547968A (ja)
EP (1) EP0501678B1 (ja)
JP (1) JP2511611B2 (ja)
KR (1) KR100221369B1 (ja)
AT (1) ATE137407T1 (ja)
CA (1) CA2061907C (ja)
DE (1) DE69210286T2 (ja)
DK (1) DK0501678T3 (ja)
ES (1) ES2089387T3 (ja)
GR (1) GR3019820T3 (ja)
TW (1) TW210287B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0948333A1 (en) * 1996-11-01 1999-10-13 Alcon Laboratories, Inc. Use of a combination of carbonic anhydrase inhibitors and prostaglandins for treating glaucoma
US6214381B1 (en) 1998-09-08 2001-04-10 Effcon, Inc. Methazolamide composition and method of use
US7128903B2 (en) * 2001-10-03 2006-10-31 Innovative Pharmaceutical Concepts (Ipc) Inc. Pharmaceutical preparations useful for treating tumors and lesions of the skin and the mucous membranes and methods and kits using same
US20040225014A1 (en) * 2003-02-14 2004-11-11 Sucampo Ag Method for treating ocular hypertension and glaucoma
TWI348386B (en) * 2003-08-12 2011-09-11 R Tech Ueno Ltd Composition and method for promoting hair growth
WO2014010654A2 (ja) * 2012-07-13 2014-01-16 参天製薬株式会社 スルホンアミド化合物の組み合わせ
US9980946B1 (en) 2017-01-25 2018-05-29 Effcon Laboratories, Inc. Extended release methazolamide formulation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2053458T3 (es) * 1986-03-13 1994-08-01 Univ Columbia Utilizacion de prostaglandinas a, b y c y derivados de las mismas, para el tratamiento de la hipertension ocular y glaucoma.
EP0286903B2 (en) * 1987-04-03 2000-03-29 The Trustees Of Columbia University In The City Of New York Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure
JPH0739343B2 (ja) * 1988-10-01 1995-05-01 株式会社アールテック・ウエノ 眼圧降下剤
DE3850676T2 (de) * 1987-09-18 1994-11-03 R Tech Ueno Ltd Hypotensive okulare Mittel.
ATE162074T1 (de) * 1988-10-01 1998-01-15 R Tech Ueno Ltd Oculare hypotensive mittel

Also Published As

Publication number Publication date
DE69210286D1 (de) 1996-06-05
EP0501678A2 (en) 1992-09-02
JPH0565227A (ja) 1993-03-19
TW210287B (ja) 1993-08-01
KR100221369B1 (ko) 1999-09-15
CA2061907A1 (en) 1992-09-02
EP0501678A3 (en) 1992-12-16
CA2061907C (en) 2003-04-08
DE69210286T2 (de) 1996-09-12
ATE137407T1 (de) 1996-05-15
US5547968A (en) 1996-08-20
ES2089387T3 (es) 1996-10-01
KR920017654A (ko) 1992-10-21
GR3019820T3 (en) 1996-08-31
JP2511611B2 (ja) 1996-07-03
EP0501678B1 (en) 1996-05-01

Similar Documents

Publication Publication Date Title
AR013742A1 (es) Metodo para el tratamiento de la hipercolesterolemia con polidialilamina no substituida
MX9204381A (es) Metodo para tratar inflamacion ocular
DK0840601T3 (da) THIP til behandling af søvnforstyrrelser
DK0735868T3 (da) Anvendelse af ikke-steroide cyclooxygenaseinhibitorer til fremstilling af et medikament til behandling af forhøjet intrakul
DK0652005T3 (da) Fremgangsmåder til inhibering af endometriose
DK0432117T3 (da) Farmaceutisk præparat til behandling af inflammation
DK0459666T3 (da) Lægemidler mod impotens
ES2071227T3 (es) Composicion para gotas para los ojos.
DK0651999T3 (da) Fremgangsmåder til inhibering af livmoderfibrose
DK0625050T3 (da) TGF-BETA til forbedring af regenerering af nervevæv
DK0501678T3 (da) Behandling af okulær hypertension med en synergistisk kombination
DK0458588T3 (da) Behandling af okulær hypertension med en synergistisk kombination til okulær administration
EA199900431A1 (ru) Способ профилактики рака молочной железы
KR950702120A (ko) 골다공증 치료를 위한 포스포네이트의 용도(use of phosphonates for the treatment of osteoporosis)
DK0498144T3 (da) Anvendelse af acetyl-L-carnitin ved terapeutisk behandling af coma
DK0901790T3 (da) Anvendelse af moxonidin til behandling af neuropatisk smerte
DK0458589T3 (da) Behandling af okulær hypertension med en okulær synergistisk kombination
DK0458590T3 (da) Behandling af okulær hypertension med en synergistisk konbination
DK0458587T3 (da) Behandling af okulær hypertension med en synergistisk kombination til ophthalmisk anvendelse
DE69301387T2 (de) Behandlung des Glaukoms mit synergistischer Kombination
ATE82850T1 (de) Verwendung von 2-pyrimidinyl-1-piperazinderivaten.
DK0740657T3 (da) 4-Arylisoindoler med analgetisk virkning
DK0791355T3 (da) Fremgangsmåde til reduktion af vævsbeskadigelse forbundet med iskæmi
ATE232724T1 (de) Inhibitor von stickstoffmonoxid (no) synthase zur verhütung von typ ii diabetes
EE200100122A (et) R-(+)-alfa-(2,3-dimetoksüfenüül)-1-[2-(4-fluorofenüül)etüül]-4-piperidiinmetanooli kasutamine unehäirete raviks